Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

GSK plc sell BiotechBee

Start price
23.09.22 / 70%
Target price
Performance (%)
This prediction is currently active. Since the start of the prediction for GSK plc the price has only changed by -0.38%. This prediction currently runs until 31.12.24. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w
GSK plc 1.334%
iShares Core DAX® -2.603%
iShares Nasdaq 100 -4.130%
iShares Nikkei 225® -2.872%
iShares S&P 500 -3.881%

According to BiotechBee what are the pros and cons of GSK plc for the foreseeable future?

Could be worthwhile Investment >10% per year

Comments by BiotechBee for this prediction

In the thread GlaxoSmithKline plc diskutieren
Prediction Sell
Perf. (%) -0.38%
Target price 10.000
Ends at 31.12.24

Sell mit Kursziel 10,0